Test Price
2,700 AED✅ Home Collection Available
Eosinophilic Leukemia FISH Panel in UAE | 2700 AED | 2026 DHA Guidelines
تحليل لوحة سرطان الدم اليوزيني (FISH) في الإمارات | 2700 درهم | معتمد من هيئة الصحة بدبي
Clinical & Service Highlights
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified laboratory processing – results trusted by DHA-registered oncologists and hematologists.
- Premium Logistics: Paid Hospital-Grade Home Collection, strictly maintained ISO Certified Cold-Chain transport for bone marrow or peripheral blood specimens; VIP Mobile Phlebotomy available.
- Clinical Guidance: Complimentary telephonic post‑test clinical correlation session to translate FISH findings into actionable treatment decisions.
- Insurance Direct Billing: Verify your coverage instantly via WhatsApp at +971 54 548 8731.
نضمن أعلى دقة تشخيصية بنسبة 99.9% عبر مختبر معتمد دولياً وفق معيار ISO 9001:2015، مع خدمة سحب منزلي طبية متميزة وشحن مبرد متوافق مع معايير الجودة، وإرشاد طبي هاتفي بعد الفحص لتفسير النتائج، وإمكانية التحقق الفوري من التغطية التأمينية عبر واتساب.
Test Overview
The Eosinophilic Leukemia FISH Panel uses Fluorescence In‑Situ Hybridization to detect cryptic rearrangements in PDGFRA, PDGFRB, FGFR1, and PCM1‑JAK2 – critical biomarkers that define eosinophilic myeloid/lymphoid neoplasms and dictate targeted therapy with tyrosine kinase inhibitors such as imatinib. يكشف تحليل FISH بدقة عن طفرات جينية خفية في PDGFRA وPDGFRB وFGFR1 وPCM1‑JAK2، مما يوجه التشخيص الدقيق لسرطان الدم اليوزيني واختيار العلاج الموجه المناسب.
| Feature | Our Eosinophilic Leukemia FISH Panel | Alternative (Conventional Cytogenetics) |
|---|---|---|
| Target Resolution | Single‑cell, locus‑specific detection of submicroscopic rearrangements | Karyotype banding; misses cryptic 4q12 or 5q31‑33 lesions |
| Turnaround Time | 3–4 days (ready for rapid clinical decision‑making) | 7–14 days, often requires culture step |
| Clinical Actionability | Directly qualifies patient for imatinib therapy if PDGFRA/PDGFRB‑positive | Limited; must refer to FISH or reverse‑transcriptase PCR |
Physician Insight & Safety – Dr. PRABHAKAR REDDY (DHA: 61713011)
“As a clinician, I understand the emotional weight of waiting for a leukemia‑related result. This FISH panel provides definitive evidence of eosinophilic leukemia subtypes, but it must always be interpreted within the full clinical picture – including blood counts, symptoms, and bone marrow morphology – never in isolation. Your doctor will correlate these genetic findings with your personal history to craft a safe, tailored treatment plan.”
⚠ Medication Warning: Do not discontinue any prescribed medication, especially corticosteroids or tyrosine kinase inhibitors, without consulting your physician. Abrupt cessation can trigger severe disease flares.
Patient Exclusion Criteria & Emergency Red Flags
- Do not schedule home collection if you have active, uncontrolled bleeding or known hemodynamic instability – seek immediate hospital care.
- This test requires a bone marrow or peripheral blood sample; patients with severe coagulopathy or platelet count <20×10⁹/L must be assessed in a hospital setting.
- If you experience sudden vision loss, splenic infarction pain (left shoulder/abdominal), or neurological symptoms such as seizures, go to the nearest emergency department – these may indicate leukostasis.
- ER Red Flag: Respiratory distress, altered mental status, or signs of stroke – dial 998 and inform the team of your suspected hematological condition.
Frequently Asked Questions
1. What does the eosinophilic leukemia FISH panel detect?
Snippet: The panel identifies rearrangements of PDGFRA, PDGFRB, FGFR1, and PCM1‑JAK2 genes at the single‑cell level, confirming the World Health Organization‑defined myeloid/lymphoid neoplasms with eosinophilia.
تكشف اللوحة عن إعادة الترتيب الجيني في جينات PDGFRA وPDGFRB وFGFR1 وPCM1‑JAK2 على مستوى الخلية الواحدة، مما يؤكد تشخيص الأورام النقوية/اللمفاوية المصحوبة بكثرة اليوزينيات وفق تصنيف منظمة الصحة العالمية.
2. How is the sample collected and what is the turnaround time?
Snippet: A DHA‑licensed phlebotomist collects bone marrow aspirate or peripheral blood during a quick, sterile procedure; results are delivered within 3–4 working days.
يُجمع فني مختبر مرخص من هيئة الصحة بدبي عينة من نخاع العظم أو الدم المحيطي بإجراء سريع ومعقم، وتُصدر النتائج خلال 3 إلى 4 أيام عمل.
3. Is a doctor’s prescription mandatory for this test?
Snippet: A valid doctor's prescription is required, except when the is performed for pre‑surgical clearance, pregnancy‑related evaluation, or travel abroad planning.
يجب تقديم وصفة طبية سارية، ويُستثنى من ذلك إجراء التحليل لغرض التخليص الجراحي أو تقييم الحمل أو التخطيط للسفر إلى الخارج.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians